PRA Health Sciences, Inc. (NASDAQ:PRAH) on 18 February 2015, reported its financial results for the fourth quarter ended December 31, 2014. For the three months ended December 31, 2014, the Company’s service revenues were $323.8 million, which represents growth of 8%, or $25.0 million, compared to the fourth quarter of 2013 at actual foreign exchange rates. On a constant currency basis, service revenue grew $29.7 million, representing growth of 10% compared to the fourth quarter of 2013. On Wednesday shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) closed at $31.07. Company’s sales growth for last 5 years was 26.20% and EPS growth for next 5 years is recorded as 19.50%.
Analysts at Zacks reiterated an “underperform” rating and set a $11.00 price target on shares of The AES Corporation (NYSE:AES) in a research note on Monday. The AES Corporation (NYSE:AES) in last trading activity fell -0.99% to close at $12.00. Company weekly performance is 1.44% while its quarterly performance stands at -14.22%. The AES Corporation (NYSE:AES) is -22.17% away from its 52 week high.
Valeant Pharmaceuticals International Inc. (NYSE:VRX) has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. The companies said Sunday that their boards of directors approved the transaction, which amounts to about $158 for each of Salix’s outstanding shares—just above the Raleigh, North Carolina-based Salix’s closing price of $157.85 per share on Friday. On last trading day Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell -1.98% to close at $198.00. Its volatility for the week is 3.62% while volatility for the month is 2.54%. VRX’s sales growth for past 5 years was 50.10% and its EPS growth for past 5 years was -33.00%. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) monthly performance is 23.86%.
R.R. Donnelley & Sons Company (NASDAQ:RRD) reported financial results for the fourth quarter and full year of 2014. Fourth-quarter net sales of $3.1 billion grew 11.4 percent from the fourth quarter of 2013; organic net sales grew 0.5 percent from the fourth quarter of 2013. R.R. Donnelley & Sons Company (NASDAQ:RRD) has 1.27% insider ownership while its institutional ownership stands at 88.50%. In last trading activity company’s stock closed at $18.85.
First Solar, Inc. (NASDAQ:FSLR) said late Tuesday that it earned $1.89 a share in the fourth quarter, surpassing the 77 cents expected by analysts polled by FactSet, but its quarterly sales of $1 billion missed estimates for $1.28 billion First Solar, Inc. (NASDAQ:FSLR) in last trading activity moved up 7.02% to close at $58.54. Company weekly performance is 19.86% while its quarterly performance stands at 17.64%. First Solar, Inc. (NASDAQ:FSLR) is -21.78% away from its 52 week high.